Evidence map›Paper›PMID 26861143›Full record

ArticleThe international journal of neuropsychopharmacology2016

A Functional Vesicular Monoamine Transporter 1 (VMAT1) Gene Variant Is Associated with Affect and the Prevalence of Anxiety, Affective, and Alcohol Use Disorders in a Longitudinal Population-Representative Birth Cohort Study.

Mariliis Vaht, Evelyn Kiive, Toomas Veidebaum, Jaanus Harro

Open access · goldAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Obesity-related RNA mJournal of neural transmission (Vienna, Austria : 1996) · 2026
    Article
  5. Review
  6. Article
  7. Associations between methamphetamine use disorder andDialogues in clinical neuroscience · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Flying Together:International journal of molecular sciences · 2020
    Review
  15. RBFOX1, encoding a splicing regulator, is a candidate gene for aggressive behavior.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2020
    Review
  16. Article
  17. Positive and balancing selection onEvolution letters · 2018
    Article
  18. Association Study of VMAT1 Polymorphisms and Suicide Behavior.Journal of molecular neuroscience : MN · 2018
    Article
  19. Personality as an intermediate phenotype for genetic dissection of alcohol use disorder.Journal of neural transmission (Vienna, Austria : 1996) · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mariliis VahtDivision of Neuropsychopharmacology, Department of Psychology, Estonian Centre of Behavioural and Health Sciences (Ms Vaht and Dr Harro), and Department of Educational Science, Faculty of Social Sciences and Education, University of Tartu, Tartu, Estonia (Dr Kiive); National Institute for Health Development, Estonian Centre of Behavioural and Health Sciences, Tallinn, Estonia (Dr Veidebaum).
Evelyn KiiveDivision of Neuropsychopharmacology, Department of Psychology, Estonian Centre of Behavioural and Health Sciences (Ms Vaht and Dr Harro), and Department of Educational Science, Faculty of Social Sciences and Education, University of Tartu, Tartu, Estonia (Dr Kiive); National Institute for Health Development, Estonian Centre of Behavioural and Health Sciences, Tallinn, Estonia (Dr Veidebaum).
Toomas VeidebaumDivision of Neuropsychopharmacology, Department of Psychology, Estonian Centre of Behavioural and Health Sciences (Ms Vaht and Dr Harro), and Department of Educational Science, Faculty of Social Sciences and Education, University of Tartu, Tartu, Estonia (Dr Kiive); National Institute for Health Development, Estonian Centre of Behavioural and Health Sciences, Tallinn, Estonia (Dr Veidebaum).
Jaanus HarroDivision of Neuropsychopharmacology, Department of Psychology, Estonian Centre of Behavioural and Health Sciences (Ms Vaht and Dr Harro), and Department of Educational Science, Faculty of Social Sciences and Education, University of Tartu, Tartu, Estonia (Dr Kiive); National Institute for Health Development, Estonian Centre of Behavioural and Health Sciences, Tallinn, Estonia (Dr Veidebaum). jaanus.harro@ut.ee.
National Institute for Health Development · EEUniversity of Tartu · EE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInter-individual differences in the monoaminergic systems have been shown to moderate the risk for a lifetime history of anxiety, affective, and alcohol use disorders. A common single nucleotide polymorphism in the vesicular monoamine transporter 1 gene (VMAT1 rs1390938 G/A; Thr136Ile) has been reported as functional in vitro and associated with bipolar disorder and anxiety. We aimed at assessing the association between the VMAT1 genotype, affect, and affect-related psychiatric disorders in a longitudinal population-representative study.

methodsWe used the database of the Estonian Children Personality Behaviour and Health Study (beginning in 1998). Cohorts of initially 9- (recalled at ages 15 and 18 years, n=579) and 15- (recalled at ages 18 and 25 years; n=654) year-old children provided self-reports on impulsivity, anxiety, depressiveness, neuroticism, and alcohol use. In addition, psychiatric assessment based on DSM-IV was carried out in the older cohort at age 25 years.

resultsSubjects homozygous for the less prevalent A (136Ile) allele reported lower maladaptive impulsivity, state and trait anxiety, depressiveness, and neuroticism and were less likely to have been diagnosed with an affective, anxiety, and/or alcohol use disorder by young adulthood. While in the younger cohort alcohol use started at younger age, this birth cohort effect was dependent on genotype: only G allele carriers and in particular the GG homozygotes started alcohol use earlier.

conclusionsVMAT1 rs1390938/Thr136Ile is associated with mood, personality, and alcohol use in the general population. Subjects homozygous for the "hyperfunction" allele (AA; Ile/Ile) appear to be more resilient to these disorders.

Indexed as

AdolescentAdultAffectAlcoholismAllelesAnxiety DisordersDatabases, FactualFemaleGenetic Predisposition to DiseaseGenotypeHumansLongitudinal StudiesMaleMood DisordersPolymorphism, Single NucleotidePrevalenceSLC18A1 protein, humanVesicular Monoamine Transport Proteinsaffective disordersalcohol useanxietycohort effectVMAT1

Identifiers

PMID26861143
PMCPMC4966275
OpenAlexW2253129521

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.